Delaware overrides veto on cannabis zoning
Delaware overrides veto on cannabis zoning, cutting buffers from 3 miles to 0.5 mile and 500 feet, forcing counties to relax local retail bans after July 1.
Author: WeedMan
German pharmacies question medical cannabis origins
Some German pharmacies receive COAs listing Portugal while flower was grown in Thailand. Scrutiny grows as pharmacies demand EU-GMP proof for medical
cannabis industry reports week ending July 4, 2026
cannabis industry roundup week ending July 4, 2026: OCS labour deal, C3 exit, regulatory reform calls, seizures, retail licenses and international policy
Georgia expands medical cannabis options
medical cannabis patients in Georgia can buy buds, THC gummies and 50-60% vape oils after state ends 5% cap; cards in 2–3 days and pharmacies can dispense.
Study: cannabis terpenes alter THC receptor activity
Study finds cannabis terpenes change THC activity at CB1 and CB2; some terpenes boost THC, supporting targeted terpene-cannabinoid medical formulations.
DEA Hearing Tests cannabis rescheduling Proposal
DEA hearing on cannabis rescheduling draws seven opposition groups; FDA witness defends 252-page HHS analysis, two-part CAMU test, and 2023 recommendation.
Manteca cannabis sales bring $760K in 16 months
Manteca records $760,749.81 in cannabis sales over 16 months. City says three dispensaries could generate about $2M annually to fund police and
DOJ Order Leaves tribal cannabis Programs Out
DOJ moved FDA-approved medical cannabis to Schedule III but omitted tribal cannabis programs, leaving questions on DEA registration, supply and tax policy.
medical cannabis shifts toward FDA-style pharmacy care
medical cannabis operators must adopt pharmacy-style GMP/GDP controls, HIPAA-grade records and clinician training after DOJ reschedules to Schedule 3.
terrascend acquisition expands New Jersey retail
TerrAscend signs agreement to buy Aunt Mary’s Dispensary in Flemington. terrascend acquisition totals $9M; Aunt Mary’s reports $10M+ annual revenue; 5,200ft